Solventum Corp
SOLVNYSECIK 1964738HealthcareFiscal year ends Dec 31
Reports and events: 44 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0517:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001964738-26-000047 |
| 2026-08-0516:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-26-000045 |
| 2026-08-0516:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-26-000043 |
| 2026-07-2016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001964738-26-000038 |
| 2026-06-0516:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-26-000036 |
| 2026-05-2716:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-26-000031 |
| 2026-05-2016:14 ET | 8-K | 5.07 Shareholder vote results | 0001964738-26-000027 |
| 2026-05-0517:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001964738-26-000024 |
| 2026-05-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-26-000022 |
| 2026-03-2716:15 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001964738-26-000017 |
| 2026-03-2416:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-26-000013 |
| 2026-02-2713:40 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001964738-26-000007 |
| 2026-02-2616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-26-000005 |
| 2025-12-1609:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001964738-25-000094 |
| 2025-11-0617:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001964738-25-000091 |
| 2025-11-0616:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-25-000089 |
| 2025-10-2117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-045731 |
| 2025-09-0816:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-25-000084 |
| 2025-09-0208:01 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001964738-25-000078 |
| 2025-08-2208:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001964738-25-000073 |
| 2025-08-1516:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-031512 |
| 2025-08-1316:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-030803 |
| 2025-08-0818:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001964738-25-000064 |
| 2025-08-0716:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-25-000062 |
| 2025-06-2516:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001964738-25-000056 |
| 2025-05-0912:24 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001964738-25-000051 |
| 2025-05-0816:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-25-000049 |
| 2025-05-0216:12 ET | 8-K | 5.07 Shareholder vote results | 0001964738-25-000043 |
| 2025-03-2116:12 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001964738-25-000038 |
| 2025-02-2816:56 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001964738-25-000019 |
| 2025-02-2716:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001964738-25-000015 |
| 2025-02-2716:12 ET | 8-K | 2.02 Results of operations | 0001964738-25-000013 |
| 2024-11-0815:57 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001964738-24-000044 |
| 2024-11-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-24-000040 |
| 2024-11-0516:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-24-000036 |
| 2024-09-2617:27 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001964738-24-000027 |
| 2024-08-0913:54 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001964738-24-000020 |
| 2024-08-0816:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001964738-24-000017 |
| 2024-05-1717:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001964738-24-000014 |
| 2024-05-1009:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001964738-24-000013 |
| 2024-05-0906:50 ET | 8-K | 2.02 Results of operations | 0001964738-24-000012 |
| 2024-04-1616:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001964738-24-000010 |
| 2024-04-0416:41 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-014887 |
| 2024-03-1317:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-010988 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.